Gebelikte Covid-19 Hastalığının Yenidoğan Tarama ABR Sonuçlarına Etkisi

Objective: In our study, it was aimed to compare the newborn screening ABR (Auditory Brainstem Responses, AABR) results of babies of mothers who had COVID-19 disease during pregnancy and babies of mothers who did not have COVID-19 disease. Methods: Newborns who underwent hearing screening tests in …. Hospital Audiology Unit between April 2019 and September 2021 were included in the study, and newborns whose mothers had COVID-19 disease during pregnancy were called Group 1, and those who did not have were called Group 2. Statistical difference was studied by comparing these two groups by their birth weight, week of birth, type of delivery, first hearing test result, and referral to a reference center. Results: A total of 746 newborn babies, 472/746 (63.3%) female and 274/746 (36.7%) males, were included in our study. There were 202/746 (27.1%) newborns in Group 1 and 544/746 (72.9%) newborns in Group 2. There was no statistically significant difference between the two groups in terms of testing age (p>0.05). When the right and left ears were evaluated separately in two groups in terms of passing the first test; no statistically significant difference was found in terms of passing the hearing test for the right and left ears, respectively (p=0.234, p=0.15). There was no statistically significant difference between the two groups in terms of birth weight and referral to a reference center (p>0.05), (p=0.775). Conclusion: The COVID-19 disease of the mother during pregnancy does not affect the newborn hearing screening results.